Global Radiation Oncology Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Radiation Oncology Market is presumed to reach the market size of nearly USD 28.92 Billion by 2032 from USD 9.91 Billion in 2023 with a CAGR of 12.64% under the study period 2024-2032.

Oncology is the treatment of cancer, and radiation oncology is the treatment of cancer through radiation therapy. Radiation therapy or radiotherapy is a therapy that utilizes ionizing radiation, usually provided for cancer treatment, to control or kill malignant cells. A linear accelerator usually delivers it. It uses a keenly targeted and regulated amount of high-energy radiation to kill cancer cells. The radiation beams change the DNA makeup of the tumor, causing it to shrink or die. This type of treatment has fewer side effects than chemotherapy.

MARKET DYNAMICS

Cancer has become more prevalent in recent times than ever, due to which the demand for radiation oncology is growing. As more people learn about radiation therapy's benefits over chemotherapy, most cancer patients tend to switch to radiation therapy, thus increasing its demand. Technological advancements in radiation therapy are also a leading cause of the growth of the radiation therapy market. Many countries are also investing their resources in research relating to radiation therapy which further increases its demand. The demand for radiation therapy is anticipated to grow as many emerging nations might access high-quality healthcare. One drawback faced by the radiation therapy market is the scarcity of qualified radiotherapy specialists.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Radiation Oncology. The growth and trends of Radiation Oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Radiation Oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

External Beam Radiation Therapy (Linear Accelerators (Linac), Compact advanced radiotherapy systems (Cyberknife, Gamma Knife, Tomotherapy), Proton Therapy (Cyclotron, Synchrotron))
Internal Beam Radiation Therapy (Brachytherapy (Seeds, Applicators and After loaders, Electronic Brachytherapy), Systemic Beam Radiation Therapy, Others)

By Technology

External Beam Radiation Therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Volumetric Modulated Arc Therapy (VMAT))
Brachytherapy (Low-Dose Rate Brachytherapy, High-Dose Rate Brachytherapy)

By Application

External Beam Radiation Therapy
Internal Beam Radiation Therapy

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Radiation Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Radiation Oncology market include Varian Medical Systems Inc., Elekta AB, Accuray Incorporated, IBA Radiopharma Solutions, BD, Isoray Medical, Mevion Medical Systems Inc., Nordion Inc., NTP Radioisotopes SOC Ltd., Curium Pharma, Viewray Technologies Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11219481

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. RADIATION ONCOLOGY - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Application
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data Analysis By Type
5.3. External Beam Radiation Therapy (Linear Accelerators (Linac), Compact advanced radiotherapy systems (Cyberknife, Gamma Knife, Tomotherapy), Proton Therapy (Cyclotron, Synchrotron)) Historic and Forecast Sales By Regions
5.4. Internal Beam Radiation Therapy (Brachytherapy (Seeds, Applicators and After loaders, Electronic Brachytherapy), Systemic Beam Radiation Therapy, Others) Historic and Forecast Sales By Regions

6. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data Analysis By Technology
6.3. External Beam Radiation Therapy (Image-Guided Radiotherapy (IGRT), Intensity Modulated Radiotherapy (IMRT), Stereotactic Technology, Proton Beam Therapy, 3D Conformal Radiotherapy (3D CRT), Volumetric Modulated Arc Therapy (VMAT)) Historic and Forecast Sales By Regions
6.4. Brachytherapy (Low-Dose Rate Brachytherapy, High-Dose Rate Brachytherapy) Historic and Forecast Sales By Regions

7. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY APPLICATION

7.1. Overview By Application
7.2. Historical and Forecast Data Analysis By Application
7.3. External Beam Radiation Therapy Historic and Forecast Sales By Regions
7.4. Internal Beam Radiation Therapy Historic and Forecast Sales By Regions

8. GLOBAL RADIATION ONCOLOGY MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE RADIATION ONCOLOGY COMPANIES

9.1. Radiation Oncology Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF RADIATION ONCOLOGY INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Varian Medical Systems Inc.
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Elekta AB
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. Accuray Incorporated
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. IBA Radiopharma Solutions
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. BD
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. Isoray Medical
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Mevion Medical Systems Inc.
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. Nordion Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. NTP Radioisotopes SOC Ltd.
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Curium Pharma
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Viewray Technologies Inc
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies